| Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II Study (NCT04762030) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-02-08 |
| Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma (NCT04713761) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-02-01 |
| Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell Carcinoma (NCT04716751) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-02-01 |
| Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor (NCT04667793) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-01-31 |
| Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer (NCT04702009) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-01-20 |
| Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients (NCT04696939) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-01-01 |
| Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis (NCT04511897) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-01-01 |
| Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy (NCT04775901) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-11-25 |
| Serum Autoantibodies in Predicting the Efficacy of Anti-PD-1 Treatment in Patients With Advanced NSCLC (NCT04372732) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-09-01 |
| PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer (NCT04539977) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-09-01 |
| Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation (NCT04509661) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-09-01 |
| Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid (NCT04511884) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-08-07 |
| Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma (NCT04201756) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-07-26 |
| Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer (NCT04379739) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-07-26 |
| Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer (NCT04422392) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-07-13 |
| Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors (NCT04355806) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-06-01 |
| Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility Trial (NCT03325907) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-06-01 |
| Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC (NCT04360655) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-05-01 |
| Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients (NCT04229121) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-01-15 |
| A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer (NCT07121387) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-01-01 |
| Updated Severity and Prognosis Score of Pulmonary Alveolar Proteinosis (NCT04516577) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-01-01 |
| Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients (NCT04203095) | Shanghai Pulmonary Hospital, Shanghai, China | 2019-11-10 |
| Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer (NCT04156360) | Shanghai Pulmonary Hospital, Shanghai, China | 2019-11-01 |
| Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation (NCT04137718) | Shanghai Pulmonary Hospital, Shanghai, China | 2019-10-25 |
| Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm (NCT04937283) | Shanghai Pulmonary Hospital, Shanghai, China | 2019-10-01 |
| Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm (NCT05838053) | Shanghai Pulmonary Hospital, Shanghai, China | 2019-08-20 |
| Identification of Microbiome and Metabolome of Bronchiectasis in Chinese Population. (NCT04490447) | Shanghai Pulmonary Hospital, Shanghai, China | 2019-08-01 |
| VATS VS. Open Thoracic Surgery for Stage II - III Lung Cancer (NCT04009915) | Shanghai Pulmonary Hospital, Shanghai, China | 2019-06-01 |
| The Establishment of China Bronchiectasis Registry and Research Collaboration (NCT03643653) | Shanghai Pulmonary Hospital, Shanghai, China | 2019-01-01 |
| Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules (NCT04554875) | Shanghai Pulmonary Hospital, Shanghai, China | 2019-01-01 |
| NGS Combined With RNAseq on Tumor Immune Escape in NSCLC (NCT03764917) | Shanghai Pulmonary Hospital, Shanghai, China | 2018-12-01 |
| Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis (NCT03643263) | Shanghai Pulmonary Hospital, Shanghai, China | 2018-06-25 |
| Idiopathic Bronchiectasis and Pulmonary Hypertension (NCT03883048) | Shanghai Pulmonary Hospital, Shanghai, China | 2018-06-01 |
| Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation (NCT03643302) | Shanghai Pulmonary Hospital, Shanghai, China | 2018-02-01 |
| Systematic Sampling of Lymph Nodes vs. Lymphadenectomy According to Intraoperative Frozen Pathology for Pulmonary Invasive Adenocarcinoma With Ground-glass Opacity (NCT03322826) | Shanghai Pulmonary Hospital, Shanghai, China | 2017-12-08 |
| Pilot Clinical Trial of PRS TB Regimen I - Phase II (NCT03561753) | Shanghai Pulmonary Hospital, Shanghai, China | 2017-12-01 |
| Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer (NCT03331588) | Shanghai Pulmonary Hospital, Shanghai, China | 2017-11-10 |
| NTM-LD Treatment Based on GenSeizer Characteristic Gene Capture Strategy (NCT03224065) | Shanghai Pulmonary Hospital, Shanghai, China | 2017-10-09 |
| Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis (NCT02546297) | Shanghai Pulmonary Hospital, Shanghai, China | 2017-09-15 |
| Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20% (NCT03351842) | Shanghai Pulmonary Hospital, Shanghai, China | 2017-09-01 |
| EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism (NCT03002844) | Shanghai Pulmonary Hospital, Shanghai, China | 2016-12-01 |
| EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism (NCT02859077) | Shanghai Pulmonary Hospital, Shanghai, China | 2016-08-01 |
| Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) (NCT02509364) | Shanghai Pulmonary Hospital, Shanghai, China | 2015-08-01 |
| Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis (NCT02507843) | Shanghai Pulmonary Hospital, Shanghai, China | 2015-01-01 |
| Corticosteroid Treatment for Acute Respiratory Distress Syndrome (NCT02819453) | Shanghai Pulmonary Hospital, Shanghai, China | 2015-01-01 |
| Cytokine Profile of Allergic Bronchopulmonary Aspergillosis (NCT03643185) | Shanghai Pulmonary Hospital, Shanghai, China | 2014-12-01 |
| Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis (NCT02509091) | Shanghai Pulmonary Hospital, Shanghai, China | 2014-12-01 |
| The Role of KL-6 in the Clinical Diagnosis of ILD (NCT02197364) | Shanghai Pulmonary Hospital, Shanghai, China | 2013-12-01 |
| Research on New Regimens for Retreatment Pulmonary Tuberculosis (NCT02331823) | Shanghai Pulmonary Hospital, Shanghai, China | 2013-06-01 |
| Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP. (NCT01983657) | Shanghai Pulmonary Hospital, Shanghai, China | 2012-01-01 |
| Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (NCT02136992) | Shanghai Pulmonary Hospital, Shanghai, China | 2011-12-01 |
| Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis (NCT02782312) | Shanghai Pulmonary Hospital, Shanghai, China | 2011-06-01 |